Specific antibody synthesisin brain could be detected with maximal sensitivity by combining an advanced enzyme immunoassay with a sophisticated evaluation method that involves calculating the ratio between the cerebrospinal fluid (CSF)/serum quotients for specific antibodies (Q) and total lgG (Q,). This Antibody Index (Al = Q50/Q1Q0) discriminates between a bloodderived and a pathological, brain-derived specific antibody fraction in CSF and takes into account individual changes in bloodfCSF bamer function. For localsynthesis of polyclonal lgG in the central nervous system (Q> OLim), we propose the correction Al = OspedQum (OLim represents that lgG fraction in CSF originating only from blood, calculated from the individualalbumin quotient of a single patient). The normal reference range for the Al was between 0.7 and 1.3 (n = 250 control patients for each antibody species). Values of Al 1 .5 indicated a local specific antibody synthesis in the central nervous system. Sensitivity and precision were greatest if we analyzed the virus-specific antibodies in CSF and serum simultaneously with an enzyme immunoassay in continuous concentrations (arbitrary units) instead of titer steps. We have applied the method successfully to antibodies to measles, rubella, herpes simplex, vancella-zoster, human immunodeficiency virus (HIV), and cytomegalovirus, and to anti-Toxoplasma or -Borrelia antibodies. Clinical relevance is demonstrated for an acute zoster virus infection (monospecific response), chronic diseases such as HIV encephalitis with acute opportunistic Toxoplasma infection, and multiple sclerosis (secondary polyspecific response). Because both the specific antibody and total immunoglobulins of the same immunoglobulin class have the same molecular size, they must have the same barrier permeabifity.
in a pathologically increased CSF protein content, the ratios between the immunoglobulin CSF/serum quotient and the albumin quotient are changed, one of us developed an evaluation diagram (5) serum-derived proteins by modifying the molecular size-dependent constants in the hyperbolic function (6) .
Moreover,
strong evidence indicates that the pathologically increased protein content in CSF in neurological diseases is mainly a function of a decreased CSF flow (9), increasing the time for influx of the bloodderived proteins into CSF (10).
These improved evaluation methods eliminated many faults in interpretation of CSF data. The introduction of the IgA and 1gM quotient diagrams increased the clinical relevance of CSF data in differential diagnosis of inflammatory neurological diseases (6) . The introduction of sensitive methods like enzyme immunoassays (EIAs) and qualitative methods like immunoblot (11), Western blot (12) , or immunospot assay (13, 14) to identify an antigen-specific response offered the potential of improved sensitivity and specificity of diagnoses of neurological diseases. Again, identification of a local synthesis of antibody in the central nervous system (CNS) by CSF analysis requires a sensitive, quantitative method to discriminate between the CSF antibody fraction originating from blood and that from an intrathecal synthesis.
As shown for the iminunoglobulin classes IgG, IgA, or 1gM (6), QMb Because both the specific antibody and total immunoglobulins of the same immunoglobulin class have the same molecular size, they must have the same barrier permeabifity.
Consequently, the ratio between the specific antibody CSF/seruxn quotient (Q) and Q, should equal 1.0 in normal conditions and should increase in cases of additional synthesis of a specific antibody in the brain. (15) as the specific Antibody Index: Al = Q8/Q,. 
This linear ratio has been introduced

Patients
The data originated from patients of the Neurological University Clinic, Gottingen, routinely analyzed during 1989. The final diagnoses of the diseases studied in this paper were based on clinical and neurochemical data together with usual electrophysiological methods and neuroimaging (18). The control group resembled those patients for whom a suggested neurological base of disease could be excluded (e.g., headache without an organic origin).
Results
Method
The representative standard curves
in Figure 1 Index shows a still larger CV (Table 1) .
In single cases, we obtained a maximal variation for the Antibody Index of CV = 30%, the sum of the variances from four different determinations. The Q diagram in Figure 2b represents the data for a multiple sclerosis patient with an intrathecally i.e., with increasing Qb (Figure 2) . As shown in Figure 3 Patient I shows in both punctures normal O, (Q,1,, < 6.5-lO-, age-dependentlimit). i.e., no blood/CSF barrier dysfunction, in contrastto patient2, who has a blood/CSF barrier dysfunction and an additional intrathecal synthesis of lgG, IgA, and 1gM.The antibody values given above (and in Table 3 Table 2 ). These data for control group Index values in comparison with other CSF data.
Evaluationof Specific AntibodyQuotients
HIlT encephalitis with an opportunistic
Toxoplasma infection: Figure 3 shows the immunoglobulin quotients for IgG, IgA, and 1gM (6) in different phases of HIV encephalitis. Neither an increased HIV-Al nor a general humoral immune reaction could be observed; there were no oligoclonal bands (8) or activated B-lymphocytes (20) . The second puncture in a Fig. 3 . 'CSF punctures of the same patient about two months (la) and eight months (lb) after infection. 5Patient 2 also had an opportunistic acute Toxoplasma infection. Table 4 ).
Zoster oticus: The sensitivity of the method is demonstrated in Figure 2a Multiple sclerosis: The patient with multiple sclerosis (Figure 2b) shows a typical set of data: a normal blood! CSF barrier function, but a large humoral immune response, which could be identified easily by an increased IgG quotient, the small pleocytosis (11 cells4L of CSF), and a few activated B-lymphocytes (IgG class). These data alone would not be sufficient to confirm the 
